ID   SC-1 [Human Cetus]
AC   CVCL_3435
SY   CTCC #0082
DR   CLO; CLO_0008956
DR   ATCC; CRL-8756
DR   BioSample; SAMN03471209
DR   LINCS_LDP; LCL-1944
DR   Wikidata; Q54952225
RX   Patent=US4683195;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8756.
CC   Sequence variation: Mutation; HGNC; 4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (Patent=US4683195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-8756; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8756
ST   Amelogenin: X,Y
ST   CSF1PO: 7.3,10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 6,9
ST   vWA: 14
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
RX   Patent=US4683195;
RA   Mullis K.B., Erlich H.A., Arnheim N., Horn G.T., Saiki R.K.,
RA   Scharf S.J.;
RT   "Process for amplifying, detecting, and/or-cloning nucleic acid
RT   sequences.";
RL   Patent number US4683195, 28-Jul-1987.
//